UB728
ProductSimvastatine tablet
Strength10mg 20mg 40mg 80mg
IndicationsHypercholesterolaemia; Low density lipoprotein increased; Apolipoprotein B increased; Hypertriglyceridaemia; High density lipoprotein decreased; Cardiovascular event prevention
TherapeuticsCardiovascular; Metabolic & Endocrinology
GMPUS - FDA; UK - MHRA
RegistrationUnited States
ModalitiesSmall Molecule
Exclusive Summary
- Backed by highly prestigious US-FDA and UK-MHRA GMP certifications alongside current US registration, validating uncompromising quality and enabling accelerated market access globally.
- Offers a complete dosage range (10-80mg) addressing comprehensive clinical needs for moderate-to-high intensity lipid-lowering therapies as recommended by the AHA/ESC, while being a staple of the WHO Essential Medicines List.
- Targets the immense global cardiovascular disease burden leveraging China's resilient supply chain to deliver exceptional cost competitiveness, creating highly profitable commercial distribution opportunities via originator substitution.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →